 0 Table of Contents |
  1 Home |
  2 Artifacts Summary |
   2.1 Diagnostic Implication |
   2.2 Gene Implication |
   2.3 Genomics Research Study |
   2.4 Genomics Variant |
   2.5 Prognostic Implication |
   2.6 Reference Citation |
   2.7 Therapeutic Implication |
   2.8 Variant Implication |
   2.9 Distance To Nearest Recruiting Location |
   2.10 References |
   2.11 Variants Assessed |
   2.12 Diseases |
   2.13 GenomOncology Diagnosis Status |
   2.14 GenomOncology Mutation Types |
   2.15 GenomOncology Prognoses |
   2.16 GenomOncology Prognosis Tier Values |
   2.17 GenomOncology Therapeutic Response |
   2.18 GenomOncology Therapeutic Settings |
   2.19 GenomOncology Therapeutic, Prognostic, and Diagnostic Sources |
   2.20 GenomOncology Variant Significance |
   2.21 GenomOncology Variant Tier Values |
   2.22 GenomOncology Diagnosis Codes |
   2.23 GenomOncology Diagnosis Status |
   2.24 GenomOncology Gene Codes |
   2.25 GenomOncology Mutation Types |
   2.26 GenomOncology Observations |
   2.27 GenomOncology Prognosis |
   2.28 GenomOncology Prognosis Codes |
   2.29 GenomOncology Prognosis Tiers |
   2.30 GenomOncology Therapeutic Codes |
   2.31 GenomOncology Therapeutic Responses |
   2.32 GenomOncology Therapeutic Settings |
   2.33 GenomOncology Therapeutic, Prognostic, and Diagnostic Sources |
   2.34 GenomOncology Variant Codes |
   2.35 GenomOncology Variant Significance |
   2.36 GenomOncology Variant Tiers |